Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignancies
Xu, Linlin, Shadman, Mazyar, Flinn, Ian W, Levy, Moshe Y, Porter, Ryan, Burke, John M, Zafar, Syed F, Cultrera, Jennifer L, Misleh, Jamal, Kingsley, Edwin C, Yimer, Habte A, Freeman, Benjamin, Chaudhry, Arvind, Tumula, Praveen K, Gandhi, Mitul D, Crescenzo, Rocco, By, Kunthel, Cohen, Aileen, Chen, Dih-Yih, Idoine, Adam, Manda, Sudhir, Sharman, Jeff P, Ramakrishnan, Vanitha
Published in Haematologica (Roma) (01.07.2024)
Published in Haematologica (Roma) (01.07.2024)
Get full text
Journal Article
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial
Bahlis, Nizar J., Costello, Caitlin L., Raje, Noopur S., Levy, Moshe Y., Dholaria, Bhagirathbhai, Solh, Melhem, Tomasson, Michael H., Damore, Michael A., Jiang, Sibo, Basu, Cynthia, Skoura, Athanasia, Chan, Edward M., Trudel, Suzanne, Jakubowiak, Andrzej, Gasparetto, Cristina, Chu, Michael P., Dalovisio, Andrew, Sebag, Michael, Lesokhin, Alexander M.
Published in Nature medicine (01.10.2023)
Published in Nature medicine (01.10.2023)
Get full text
Journal Article
A phase 2, multicentre, open‐label trial (ACE‐LY‐003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma
Strati, Paolo, Coleman, Morton, Champion, Rebecca, Ma, Shuo, Patti, Caterina, Levy, Moshe Y., Lossos, Izidore S., Geethakumari, Praveen Ramakrishnan, Lam, Selay, Calvo, Roser, Higgins, Kara, Budde, Lihua E.
Published in British journal of haematology (01.10.2022)
Published in British journal of haematology (01.10.2022)
Get full text
Journal Article
A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML
Fathi, Amir T., Erba, Harry P., Lancet, Jeffrey E., Stein, Eytan M., Ravandi, Farhad, Faderl, Stefan, Walter, Roland B., Advani, Anjali S., DeAngelo, Daniel J., Kovacsovics, Tibor J., Jillella, Anand, Bixby, Dale, Levy, Moshe Y., O'Meara, Megan M., Ho, Phoenix A., Voellinger, Jenna, Stein, Anthony S.
Published in Blood (13.09.2018)
Published in Blood (13.09.2018)
Get full text
Journal Article
Dose-escalation of second-line and first-line asciminib in chronic myeloid leukemia in chronic phase: the ASC2ESCALATE Phase II trial
Atallah, Ehab L, Mauro, Michael J, Sasaki, Koji, Levy, Moshe Y, Koller, Paul, Yang, Daisy, Laine, Dramane, Sabo, John, Gu, Ennan, Cortes, Jorge E
Published in Future oncology (London, England) (10.10.2024)
Published in Future oncology (London, England) (10.10.2024)
Get more information
Journal Article
Randomized Phase III SIERRA Trial of 131 I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML
Gyurkocza, Boglarka, Nath, Rajneesh, Seropian, Stuart, Choe, Hannah, Litzow, Mark R, Abboud, Camille, Koshy, Nebu, Stiff, Patrick, Tomlinson, Benjamin, Abhyankar, Sunil, Foran, James, Hari, Parameswaran, Chen, George, Al-Kadhimi, Zaid, Kebriaei, Partow, Sabloff, Mitchell, Orozco, Johnnie J, Jamieson, Katarzyna, Silverman, Margarida, Van Besien, Koen, Schuster, Michael, Law, Arjun Datt, Larkin, Karilyn, Pandit-Taskar, Neeta, Rowley, Scott D, Munshi, Pashna, Cook, Rachel, Levy, Moshe Y, Lazarus, Hillard M, Sandmaier, Brenda M, Pagel, John M, Reddy, Vijay, MacDougall, James, McNamara, Kathleen, Spross, Jennifer, Haeuber, Elaina, Vusirikala, Madhuri, Nahar, Akash, Desai, Avinash, Giralt, Sergio
Published in Journal of clinical oncology (19.09.2024)
Published in Journal of clinical oncology (19.09.2024)
Get full text
Journal Article
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study
Shadman, Mazyar, Flinn, Ian W, Levy, Moshe Y, Porter, Ryan F, Burke, John M, Zafar, Syed F, Misleh, Jamal, Kingsley, Edwin C, Yimer, Habte A, Freeman, Benjamin, Rao, Subramanya S, Chaudhry, Arvind, Tumula, Praveen K, Gandhi, Mitul D, Manda, Sudhir, Chen, Dih-Yih, By, Kunthel, Xu, Linlin, Liu, Ye, Crescenzo, Rocco, Idoine, Adam, Zhang, Xiaoping, Cohen, Aileen, Huang, Jane, Sharman, Jeff P
Published in The Lancet. Haematology (01.01.2023)
Published in The Lancet. Haematology (01.01.2023)
Get more information
Journal Article
IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid
Mazharuddin, Samir, Chattopadhyay, Anuja, Levy, Moshe Y., Redner, Robert L.
Published in Leukemia & lymphoma (02.09.2018)
Published in Leukemia & lymphoma (02.09.2018)
Get full text
Journal Article
A phase II multi-arm study of magrolimab combinations in patients with relapsed/refractory multiple myeloma
Paul, Barry, Liedtke, Michaela, Khouri, Jack, Rifkin, Robert, Gandhi, Mitul D, Kin, Andrew, Levy, Moshe Y, Silbermann, Rebecca, Cottini, Francesca, Sborov, Douglas W, Sandhu, Irwindeep, Villarreal, Lyssa, Murphy, Michael, Gu, Lin, Chen, Ann, Rajakumaraswamy, Nishanthan, Usmani, Saad Z
Published in Future oncology (London, England) (01.01.2023)
Published in Future oncology (London, England) (01.01.2023)
Get full text
Journal Article
P633: UPDATED SAFETY AND EFFICACY RESULTS OF ZANUBRUTINIB IN PATIENTS WITH B‐CELL MALIGNANCIES WHO ARE INTOLERANT OF IBRUTINIB AND/OR ACALABRUTINIB
Shadman, Mazyar, Y. Levy, Moshe, Porter, Ryan, M. Burke, John, L. Cultrera, Jennifer, Misleh, Jamal, Sharman, Jeff, F. Zafar, Syed, By, Kunthel, Cohen, Aileen, Crescenzo, Rocco, Idoine, Adam, W. Flinn, Ian
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Health care cost impact associated with adverse events (AEs) among treatments in third-line+ (3L+) relapsed/refractory follicular lymphoma (R/R FL)
Gaballa, Sameh, Levy, Moshe Y., Keith, Michael, Wong, Alex, Proudman, David, Nellesen, Dave, Mamlouk, Khalid
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
ASC2ESCALATE: A US phase 2, single-arm, dose-escalation study of asciminib monotherapy in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) previously treated with 1 prior tyrosine kinase inhibitor (TKI)
Atallah, Ehab L., Mauro, Michael J., Sasaki, Koji, Levy, Moshe Y., Koller, Paul B., Sadek, Islam, Yang, Daisy, Ruckel-Kumar, Julie, Khan, Mahmudul H, Cortes, Jorge E.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Trial in Progress: Asciminib in Monotherapy 4 CML (AIM4CML), a Phase IIIb Study of Asciminib Monotherapy in Patients with Chronic Myeloid Leukemia in Chronic Phase without or with T315I Mutations
Andorsky, David, Tomassetti, Sarah, Deutsch, Yehuda E., Broun, E Randolph, Issa, Ghayas C., Levy, Moshe Y., Deininger, Michael W., Maegawa, Rodrigo, Shrestha, Alok, Mauro, Michael J.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Trial in Progress: Phase 1b/2 Study of Alrizomadlin (APG-115), Alone or Combined with 5-Azacitidine (AZA), in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML), or Myelodysplastic Syndrome (MDS)
Kadia, Tapan M., Benton, Christopher, Erba, Harry P., Gandhi, Mitul, Levy, Moshe Y., Percival, Mary-Elizabeth M., Ulrickson, Matthew, Yimer, Habte, Yu, Min, Chen, Zi, Wang, Jing, Li, Mingyu, Ahmad, Mohammad, Yang, Dajun, Zhai, Yifan
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Comparison of Time to Next Treatment Between Patients With Chronic Lymphocytic Leukemia Initiating First-Line Ibrutinib or Acalabrutinib Overall and in a Subgroup With High-Risk Characteristics
Jacobs, Ryan, Levy, Moshe Y., Yazbeck, Victor, Lafeuille, Marie-Hélène, Emond, Bruno, Gogna, Priyanka, Maegawa, Rodrigo, Qureshi, Zaina P., Ferrajoli, Alessandra
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Get full text
Journal Article
CLL-342 Comparison of Time to Next Treatment Between Patients With Chronic Lymphocytic Leukemia Initiating First-Line Ibrutinib or Acalabrutinib Overall and in a Subgroup With High-Risk Characteristics
Jacobs, Ryan, Levy, Moshe Y., Yazbeck, Victor, Lafeuille, Marie-Hélène, Emond, Bruno, Gogna, Priyanka, Maegawa, Rodrigo, Qureshi, Zaina P., Ferrajoli, Alessandra
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Get full text
Journal Article
Poster: CML-427 AIM4CML Trial in Progress: A Phase IIIb Study of Asciminib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without the T315I Mutation
Levy, Moshe Y., Mauro, Michael J., Issa, Ghayas C., Andorsky, David, Tomassetti, Sarah, Broun, E. Randolph, Maegawa, Rodrigo, Deininger, Michael
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Get full text
Journal Article
CML-427 AIM4CML Trial in Progress: A Phase IIIb Study of Asciminib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without the T315I Mutation
Levy, Moshe Y., Mauro, Michael J., Issa, Ghayas C., Andorsky, David, Tomassetti, Sarah, Broun, E. Randolph, Maegawa, Rodrigo, Deininger, Michael
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2022)
Get full text
Journal Article
A Phase 1a/b Dose Escalation Study of the MYC Repressor Apto-253 in Patients with Relapsed or Refractory AML or High-Risk MDS
Ohanian, Maro, Arellano, Martha L., Levy, Moshe Y., O'Dwyer, Kristen, Babiker, Hani, Mahadevan, Daruka, Zhang, Hongying, Rastgoo, Nasrin, Jin, Yuying, Marango, Jotin, Howell, Stephen B, Rice, William G, Bejar, Rafael
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Molecular features and outcomes for patients receiving elranatamab for relapsed or refractory multiple myeloma in MagnetisMM-1
Tomasson, Michael H., Bahlis, Nizar J., Costello, Caitlin, Raje, Noopur S., Levy, Moshe Y., Dholaria, Bhagirathbhai R., Solh, Melhem M., Damore, Michael A., Jiang, Sibo, Xie, Tao, Basu, Cynthia, Skoura, Athanasia, Chan, Edward Michael, Trudel, Suzanne, Jakubowiak, Andrzej J., Gasparetto, Cristina, Chu, Michael, Dalovisio, Andrew Peter, Sebag, Michael, Lesokhin, Alexander M.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article